The 26 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 82.97, with a high estimate of 106.75 and a low estimate of 63.00. The median estimate represents a +22.28% increase from the last price of 67.85.
The current consensus among 31 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.88
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.